Journal of Korean Neurosurgical Society

The Korean Neurosurgical Society (대한신경외과학회)
권호 표지
DOI QR코드

DOI QR Code

Status Epilepticus Caused by Nefopam

  • Park, Yong-Sook (Department of Neurosurgery, Chung-Ang University College of Medicine) ;
  • Kim, Young-Baeg (Department of Neurosurgery, Chung-Ang University College of Medicine) ;
  • Kim, Jeong-Min (Department of Neurology, Chung-Ang University College of Medicine)
  • Received : 2013.11.24
  • Accepted : 2014.07.17
  • Published : 2014.11.28
Download PDF
⟨ Previous Next ⟩

Abstract

Nefopam, a centrally acting analgesic, has been used to control postoperative pain. Reported adverse effects are anticholinergic, cardiovascular or neuropsychiatric. Neurologic adverse reactions to nefopam are confusion, hallucinations, delirium and convulsions. There are several reports about fatal convulsive seizures, presumably related to nefopam. A 71-year-old man was admitted for surgery for a lumbar spinal stenosis. He was administered intravenous analgesics : ketorolac, tramadol, orphenadrine citrate and nefopam HCl. His back pain was so severe that he hardly slept for several days; he even needed morphine and pethidine. At 4 days of administration of intravenous analgesics, the patient suddenly started generalized tonic-clonic seizures for 15 seconds, and subsequently, status epilepticus; these were not responsive to phenytoin and midazolam. After 3 days of barbiturate coma therapy the seizures were controlled. Convulsive seizures related to nefopam appear as focal, generalized, myoclonic types, or status epilepticus, and are not dose-related manifestations. In our case, the possibility of convulsions caused by other drugs or the misuse of drugs was considered. However, we first identified the introduced drugs and excluded the possibility of an accidental misuse of other drugs. Physicians should be aware of the possible occurrence of unpredictable and serious convulsions when using nefopam.

Keywords

References

  1. Beaver WT, Feise GA : A comparison of the analgesic effect of intramuscular nefopam and morphine in patients with postoperative pain. J Clin Pharmacol 17 (10 Pt 1) : 579-591, 1977 https://doi.org/10.1177/009127007701701005
  2. Durrieu G, Olivier P, Bagheri H, Montastruc JL : French Network of Pharmacovigilance Centers : overview of adverse reactions to nefopam : an analysis of the French Pharmacovigilance database. Fundam Clin Pharmacol 21 : 555-558, 2007 https://doi.org/10.1111/j.1472-8206.2007.00499.x
  3. Fuller RW, Snoddy HD : Evaluation of nefopam as a monoamine uptake inhibitor in vivo in mice. Neuropharmacology 32 : 995-999, 1993 https://doi.org/10.1016/0028-3908(93)90064-A
  4. Godier A, Babinet A, el Metaoua S, Fulgencio JP, Bonnet F : [A new cause of postoperative confusion syndrome : nefopam]. Ann Fr Anesth Reanim 21 : 538-539, 2002 https://doi.org/10.1016/S0750-7658(02)00650-0
  5. Heel RC, Brogden RN, Pakes GE, Speight TM, Avery GS : Nefopam : a review of its pharmacological properties and therapeutic efficacy. Drugs 19 : 249-267, 1980 https://doi.org/10.2165/00003495-198019040-00001
  6. Kerr DE, Fletcher AK : Fatal nefopam overdose. Emerg Med J 27 : 407-408, 2010 https://doi.org/10.1136/emj.2009.082974
  7. Kim KH, Abdi S : Rediscovery of nefopam for the treatment of neuropathic pain. Korean J Pain 27 : 103-111, 2014 https://doi.org/10.3344/kjp.2014.27.2.103
  8. Mimoz O, Incagnoli P, Josse C, Gillon MC, Kuhlman L, Mirand A, et al. : Analgesic efficacy and safety of nefopam vs. propacetamol following hepatic resection. Anaesthesia 56 : 520-525, 2001 https://doi.org/10.1046/j.1365-2044.2001.01980.x
  9. Novelli A, Díaz-Trelles R, Groppetti A, Fernández-Sánchez MT : Nefopam inhibits calcium influx, cGMP formation, and NMDA receptor-dependent neurotoxicity following activation of voltage sensitive calcium channels. Amino Acids 28 : 183-191, 2005 https://doi.org/10.1007/s00726-005-0166-0
  10. Piercy DM, Cumming JA, Dawling S, Henry JA : Death due to overdose of nefopam. Br Med J (Clin Res Ed) 283 : 1508-1509, 1981 https://doi.org/10.1136/bmj.283.6305.1508
  11. Pillans PI, Woods DJ : Adverse reactions associated with nefopam. N Z Med J 108 : 382-384, 1995
  12. Tracqui A, Berthelon L, Ludes B : Fatal overdosage with nefopam (Acupan). J Anal Toxicol 26 : 239-243, 2002 https://doi.org/10.1093/jat/26.4.239
  13. Urwin SC, Smith HS : Fatal nefopam overdose. Br J Anaesth 83 : 501-502, 1999 https://doi.org/10.1093/bja/83.3.501
  14. Verleye M, Andre N, Heulard I, Gillardin JM : Nefopam blocks voltage-sensitive sodium channels and modulates glutamatergic transmission in rodents. Brain Res 1013 : 249-255, 2004 https://doi.org/10.1016/j.brainres.2004.04.035
  15. Villier C, Mallaret MP : Nefopam abuse. Ann Pharmacother 36 : 1564-1566, 2002 https://doi.org/10.1345/aph.1C017

Cited by

  1. A Randomized Clinical Trial of Nefopam versus Ketorolac Combined With Oxycodone in Patient-Controlled Analgesia after Gynecologic Surgery vol.12, pp.8, 2015, https://doi.org/10.7150/ijms.11828
  2. Nefopam : Status epilepticus: case report vol.1533, pp.1, 2015, https://doi.org/10.1007/s40278-015-6351-3
  3. Myoclonic movement after general anesthesia : A case report and review of the literature vol.97, pp.12, 2014, https://doi.org/10.1097/md.0000000000010141
  4. Development of postoperative central anticholinergic syndrome due to low-dose intravenous fentanyl vol.12, pp.2, 2014, https://doi.org/10.4103/sja.sja_478_17
  5. Analgesic Efficacy of Nefopam as an Adjuvant in Patient-Controlled Analgesia for Acute Postoperative Pain After Laparoscopic Colorectal Cancer Surgery vol.10, pp.2, 2021, https://doi.org/10.3390/jcm10020270